Augere Medical

About Augere Medical

Augere Medical is a commercial stage Norwegian medical device company founded in 2018 and is developing systems based on Artificial Intelligence (AI) to improve polyp detection rates during screening for colorectal cancer. The term "augere" is derived from Latin, meaning "to increase" or "to grow" - hence the green color in our logo. It is the root of several words in English and other languages, including "authority," which signifies the power to promote or bring about growth. Augere’s first product, the PolypAID System, is being developed in cooperation with leading colonoscopists and in close cooperation with the research group at Simula. The PolypAID System analyses the real-time video stream during colonoscopy screening and supports the physicians in making the right decision during the screening process. We pledge to implement transparent AI to physicians and patients. These are our values, mission, vision, and tagline statements: OUR VALUES Quality We are delivering high quality products through focus on details and by meeting customer expectations. Innovation We are in the forefront of the technology development by embracing continuous improvements and investing in our employees. Care We care about the patients who will benefit from our technologies and put real heart into our promises to our investors and customers. Agility We move fast and are willing to adapt to changing market conditions regardless of the size of the company. Delivering results We have grit to deliver results by defining clear objectives and by meeting deadlines. MISSION Making lives better VISION Augere will, through partnerships with the world's leading clinical and technical research environments, develop a platform for AI-based systems that improve the detection rate and characterization of cancer and precancerous abnormalities and thereby reduce the burden on patients and the cost of cancer treatment TAGLINE Confidence in outcomes (TM)

View contact profiles from Augere Medical